Exploring Electroporation Series Part 3: iPSC
Induced pluripotent stem cells (iPSCs) hold great potential for disease modeling, personalized medicine, and regenerative therapies. The MaxCyte electroporation technology, a non-viral cell engineering method, can efficiently deliver and maintain high cell health, facilitating the use of iPSCs. The MaxCyte ExPERT™ electroporation platform offers continuous scalability, helping scientists transition their research from the lab to the clinic. This technology has been used in various research projects, including the deletion of large DNA fragments in iPSCs, generation of heterozygous HLA-C iPSCs for transplantation, non-viral engineering of iPSCs for cancer immunotherapy, and the correction of DYSF in Miyoshi Myopathy patient iPSCs.
If you enjoy this Cell Therapy E-book, check out the remainder of the series:
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.